Ledger.Open graph →
SEC Form D · Amendment · filed November 23, 2021

Magnolia Neurosciences Corp

Offering
$18.4M
Sold
$18.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Roger Mills · Geneva, V8ExecJohn Mcmahon · SAN FRANCISCO, CADirectorMartin Dolfi · New York, NYDirectorAdele Gorrilla · Philadelphia, PAExecSteve Gillis · New York, NYDirectorThong Le · New York, NYExec · DirectorIan Howes · New York, NYExecKendall Mohler · New York, NYExecJake Nunn · Menlo Park, CADirectorIsaac Manke · New York, NYExecBill I. Koutsouras · Vancouver, British Columbia, CanadaDirectorMichael J. Baran · New York, NYDirectorAlice J. Ly · New York, NYDirectorSheona I. Docksteader · Vancouver, British Columbia, CanadaDirectorJean-Philippe Rocher · Geneva, V8DirectorSteven I. Krause · Vancouver, British Columbia, CanadaExecDean I. Sutton · Vancouver, British Columbia, CanadaExec · DirectorMikhail Kalinichev · Geneva, V8Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗